Sit Investment Associates’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-15,375
Closed -$816K 527
2021
Q3
$816K Hold
15,375
0.02% 370
2021
Q2
$938K Sell
15,375
-6,400
-29% -$340K 0.02% 370
2021
Q1
$1.06M Sell
21,775
-17,475
-45% -$819K 0.03% 355
2020
Q4
$1.59M Hold
39,250
0.04% 316
2020
Q3
$1.28M Buy
39,250
+3,750
+11% +$113K 0.04% 328
2020
Q2
$937K Buy
+35,500
New +$928K 0.03% 333

Other funds holding LMAT

Sit Investment Associates's LMAT Position: Q4 2021 in Review

Sit Investment Associates sold out of LeMaitre Vascular (LMAT) in Q4 2021, closing a stake of 15,375 shares — an estimated $816K sold.

Sit Investment Associates first reported a position in LMAT in Q2 2020 and held it in 6 quarters. The position peaked at $1.59M in Q4 2020. 183 funds tracked by Wall St. Rank hold LMAT as of Q4 2021.

  • Sit Investment Associates reported no remaining LeMaitre Vascular position as of Q4 2021 after selling out during the quarter.
  • Sit Investment Associates sold 15,375 LeMaitre Vascular shares in Q4 2021, an estimated $816K.
  • Sit Investment Associates first reported a position in LeMaitre Vascular in Q2 2020 and held it in 6 quarters.
  • Sit Investment Associates's LeMaitre Vascular position peaked at $1.59M in Q4 2020.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2021.

Based on Sit Investment Associates's 13F filing for Q4 2021, filed 11 Feb 2022.